Fusion Antibodies PLC
LSE:FAB

Watchlist Manager
Fusion Antibodies PLC Logo
Fusion Antibodies PLC
LSE:FAB
Watchlist
Price: 14 GBX -8.2% Market Closed
Market Cap: 15.9m GBX

Wall Street
Price Targets

FAB Price Targets Summary
Fusion Antibodies PLC

There are no price targets for FAB.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Fusion Antibodies PLC Competitors:
Price Targets
603259
WuXi AppTec Co Ltd
40% Upside
TKNO
Alpha Teknova Inc
97% Upside
1548
Genscript Biotech Corp
87% Upside
300759
Pharmaron Beijing Co Ltd
28% Upside
DIVISLAB
Divi's Laboratories Ltd
6% Upside
2269
WuXi Biologics (Cayman) Inc
18% Upside
237690
ST Pharm Co Ltd
0% Downside
QTRX
Quanterix Corp
1% Upside

Revenue
Forecast

Revenue Estimate
Fusion Antibodies PLC

For the last 9 years the compound annual growth rate for Fusion Antibodies PLC's revenue is 3%. The projected CAGR for the next 1 year is 18%.

3%
Past Growth
18%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Fusion Antibodies PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
11%
Average Beat

Net Income
Forecast

Net Income Estimate
Fusion Antibodies PLC

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-58%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is FAB's stock price target?
Not Available

FAB doesn't have any price targets made by Wall Street professionals.

What is Fusion Antibodies PLC's Revenue forecast?
Projected CAGR
18%

For the last 9 years the compound annual growth rate for Fusion Antibodies PLC's revenue is 3%. The projected CAGR for the next 1 year is 18%.

Back to Top